The advisers of US Food and Drug Administration (FDA) gave their nod to CAR-T Immunotherapy for treating different forms of cancers.This therapy genetically engineers the patient’s own immune cells to target the cancerous ones and destroy them.
Reference Link: http://www.nature.com/news/engineered-cell-therapy-for-cancer-gets-thumbs-up-from-fda-advisers-1.22304